Second Sight Medical Products, Inc. (EYES) Financials

NASDAQ Currency in USD Disclaimer

$4.14

north_east NA Past Year
Day's range
$4.14
Day's range
$4.35

EYES Income statement / Annual

Last year (2021), Second Sight Medical Products, Inc.'s total revenue was -$130,000.00, a decrease of 74.00% from the previous year. In 2021, Second Sight Medical Products, Inc.'s net income was -$8.93 M. See Second Sight Medical Products, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014 FY-2013 FY-2012
Period Ended 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014 12/31/2013 12/31/2012
Operating Revenue -$130,000.00 -$500,000.00 $3.38 M $6.90 M $7.96 M $3.99 M $8.95 M $3.40 M $1.56 M $1.37 M
Cost of Revenue $0.00 $0.00 $2.15 M $4.89 M $5.12 M $10.08 M $5.29 M $3.56 M $5.63 M $4.40 M
Gross Profit -$130,000.00 -$500,000.00 $1.23 M $2.01 M $2.85 M -$6.09 M $3.66 M -$160,283.00 -$4.06 M -$3.03 M
Gross Profit Ratio 1 1 0.36 0.29 0.36 -1.53 0.41 -0.05 -2.6 -2.22
Research and Development Expenses $2.37 M $4.84 M $13.14 M $10.01 M $7.89 M $5.35 M $3.04 M $5.04 M $3.25 M $3.05 M
General & Administrative Expenses $6.32 M $5.94 M $9.23 M $10.69 M $10.93 M $10.08 M $8.22 M $6.57 M $4.17 M $4.03 M
Selling & Marketing Expenses $0.00 $701,000.00 $6.10 M $11.34 M $9.57 M $8.99 M $8.94 M $6.84 M $3.30 M $2.19 M
Selling, General & Administrative Expenses $6.32 M $6.64 M $15.33 M $22.03 M $20.50 M $19.07 M $17.16 M $13.41 M $7.47 M $6.22 M
Other Expenses $378,000.00 $1.69 M $3.35 M $4.60 M $3.06 M $2.70 M $3.51 M $2.62 M $3.22 M $3.73 M
Operating Expenses $9.06 M $13.17 M $31.82 M $36.63 M $31.46 M $27.12 M $23.70 M $21.07 M $13.93 M $12.99 M
Cost And Expenses $8.93 M $12.67 M $33.98 M $41.52 M $36.57 M $37.20 M $29.00 M $24.63 M $19.56 M $17.39 M
Interest Income $12,000.00 $16,000.00 $362,000.00 $86,000.00 $93,000.00 $31,000.00 $2,000.00 $9,108.00 $7,454.00 $7,512.00
Interest Expense $12,000.00 $16,000.00 $362,000.00 $86,000.00 $93,000.00 $31,000.00 $29,000.00 $7.03 M $5.01 M $267,031.00
Depreciation & Amortization $70,000.00 $164,000.00 $397,000.00 $435,000.00 $457,000.00 $432,000.00 $335,000.00 $279,179.00 $315,770.00 $324,712.00
EBITDA -$8.84 M -$14.70 M -$32.83 M -$34.57 M -$27.97 M -$32.72 M -$19.65 M -$27.89 M -$17.64 M -$15.69 M
EBITDA Ratio 67.99 29.4 -9.72 -5.01 -3.51 -8.21 -2.2 -8.21 -11.27 -11.47
Operating Income Ratio 68.53 29.79 -10.05 -5.1 -3.59 -8.33 -2.24 -6.25 -11.5 -11.72
Total Other Income/Expenses Net -$12,000.00 $16,000.00 $362,000.00 $586,000.00 $93,000.00 $31,000.00 $29,000.00 -$13.97 M -$4.97 M -$257,744.00
Income Before Tax -$8.92 M -$14.88 M -$33.59 M -$35.09 M -$28.52 M -$33.18 M -$20.02 M -$35.20 M -$22.97 M -$16.28 M
Income Before Tax Ratio 68.62 29.76 -9.94 -5.09 -3.58 -8.33 -2.24 -10.36 -14.68 -11.91
Income Tax Expense $12,000.00 $32,000.00 $724,000.00 $172,000.00 $186,000.00 $62,000.00 $58,000.00 -$6.93 M $42,222.00 $9,287.00
Net Income -$8.93 M -$14.88 M -$33.59 M -$35.09 M -$28.52 M -$33.18 M -$20.02 M -$35.20 M -$22.97 M -$16.28 M
Net Income Ratio 68.72 29.76 -9.94 -5.09 -3.58 -8.33 -2.24 -10.36 -14.68 -11.91
EPS -0.82 -2.17 -54.81 -12.69 -12.64 -20.13 -12.37 -30.94 -14.61 -10.35
EPS Diluted -0.82 -2.17 -54.81 -12.69 -12.64 -20.13 -12.37 -30.94 -14.61 -10.35
Weighted Average Shares Out $10.94 M $6.86 M $612,833.00 $2.77 M $2.26 M $1.65 M $1.62 M $1.14 M $1.57 M $1.57 M
Weighted Average Shares Out Diluted $10.94 M $6.86 M $612,833.00 $2.77 M $2.26 M $1.65 M $1.62 M $1.14 M $1.57 M $1.57 M
Link